Loading...
Loading...
Of the 5 tracked institutions holding GENB, 3 have a 3-year clone track record — 3 of them beat the S&P. Average holder's clone alpha: +4.0pt. It's a gauge of who owns the name, not just how many.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Among the 5 tracked institutional investors we monitor, GENB (GENERATE BIOMEDICINES INC) is held with a combined value of $107.83M across 8,626,060 shares. The largest holder is FMR LLC with a position worth $52.72M. 5 funds opened new positions in the most recent quarter.
Total Institutional Value
$107.83M
Total Shares Held
8,626,060
Institutional Holders
5
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $52.72M | 0.00% | New |
| 2 | PRICE T ROWE ASSOCIATES INC /MD/ | $26.37M | 0.00% | New |
| 3 | BAKER BROS. ADVISORS LP | $17.80M | 0.10% | New |
| 4 | ARK Investment Management LLC | $6.23M | 0.05% | New |
| 5 | MILLENNIUM MANAGEMENT LLC | $4.71M | 0.00% | New |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of GENB with a position worth $52.72M, representing 0.00% of their portfolio. In total, 5 institutional investors hold GENB with a combined value of $107.83M.
In the most recent quarter, 5 funds opened a new position in GENB.
Institutional investors hold $107.83M worth of GENB stock across 5 positions. The largest institutional holder is FMR LLC with $52.72M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GENB, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GENB positions.
None this quarter.
Last Close
$13.56
2026-07-17
YTD
+7.2%
38% of 52-week range